Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use

Table 2

Blood product requirements before and after the administration of rFVIIa for major obstetric haemorrhage.

Pt no.	FFP transfused		Cryoprecipitate		Platelets transfused		Red cells transfused
	(units)		transfused (units)		(pools)		(units)
	Pre	Post	Pre	Post	Pre	Post	Pre	Post
1	2	0	10	0	0	1	8	4
2	12	0	10	0	2	0	21	3
3	4	0	9	0	2	0	12	0
4	4	0	5	5	2	0	9	2
5	4	4	0	10	0	3	11	11
6	4	0	10	0	0	2	14	12
7	7	31	8	42	1	12	21	52
8	10	6	3	0	2	2	20	10
9	0	0	0	0	0	0	0	0
10	12	0	20	10	2	0	18	0
11	4	0	0	0	0	0	11	3
12	6	15	10	10	2	5	22	20
13	8	7	0	10	2	2	15	14
14	10	0	10	0	1	0	20	10
15	4	5	30	0	1	0	6	6
Median	4	0	9	0	1	0	14	6
𝑃-value^∗	0.127		0.413		0.700		0.034

*Wilcoxon signed-rank test is shown.